Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Coppens

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Expert Review of Hematology|July 9, 2019
Switching patients in the age of long-acting recombinant products?Miguel Escobar, Elena Santagostino, Maria Elisa Mancuso, et al.
Journal of Thrombosis and Haemostasis : JTH|February 2, 2022
Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysisHanke M G Wiegers, Jannet Knijp, Nick van Es, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence ratesHanke M G Wiegers, Jannet Knijp, Nick van Es, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2022
Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolismIngrid M Bistervels, Roisin Bavalia, Martin Gebel, et al.
Thrombosis and Haemostasis|July 4, 2014
Successful co-administration of dabigatran etexilate and protease inhibitors ritonavir/lopinavir in a patient with atrial fibrillationStefano Barco, Michiel Coppens, Erik-Jan van den Dool, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trialsLuuk J J Scheres, Willem M Lijfering, Saskia Middeldorp, et al.
Blood Advances|June 23, 2023
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia BManfred Schmidt, Graham R Foster, Michiel Coppens, et al.
Thrombosis Research|October 21, 2017
Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosisRemi O Kool, Hans P Kohler, Jonathan M Coutinho, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2025
Qualification Criteria of Gene Therapy for Haemophilia-Opinion of the EAHAD Gene Therapy Working GroupWolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2023
Nitrous oxide abuse leading to extreme homocysteine levels and thrombosis in young adults: a case seriesMartine G Caris, Remko S Kuipers, Baruch E Kiestra, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Expert Review of Hematology|July 9, 2019
Switching patients in the age of long-acting recombinant products?Miguel Escobar, Elena Santagostino, Maria Elisa Mancuso, et al.
Journal of Thrombosis and Haemostasis : JTH|February 2, 2022
Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysisHanke M G Wiegers, Jannet Knijp, Nick van Es, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence ratesHanke M G Wiegers, Jannet Knijp, Nick van Es, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2022
Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolismIngrid M Bistervels, Roisin Bavalia, Martin Gebel, et al.
Thrombosis and Haemostasis|July 4, 2014
Successful co-administration of dabigatran etexilate and protease inhibitors ritonavir/lopinavir in a patient with atrial fibrillationStefano Barco, Michiel Coppens, Erik-Jan van den Dool, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trialsLuuk J J Scheres, Willem M Lijfering, Saskia Middeldorp, et al.
Blood Advances|June 23, 2023
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia BManfred Schmidt, Graham R Foster, Michiel Coppens, et al.
Thrombosis Research|October 21, 2017
Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosisRemi O Kool, Hans P Kohler, Jonathan M Coutinho, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2025
Qualification Criteria of Gene Therapy for Haemophilia-Opinion of the EAHAD Gene Therapy Working GroupWolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2023
Nitrous oxide abuse leading to extreme homocysteine levels and thrombosis in young adults: a case seriesMartine G Caris, Remko S Kuipers, Baruch E Kiestra, et al.
Pageof 15